Delivery Order SPE2DB24D2216-SPE2DB26FGLYV
- Not listed
- The Defense Logistics Agency awarded a $17,257.88 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Enbrel 50 mg/ml syringes. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Enbrel 25 mg/0.5 ml syringes valued at $2,307.34. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside, competitively awarded contract. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of ENBREL 25 mg/0.5 ml syringes. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml syringes valued at $68,950.48 on September 12, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Enbrel 50 mg/mL syringes with a ceiling value of $13,602.12. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The performance location is the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for ENBREL 50 mg/ml syringes valued at $29,284.84. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania facility with...
- The Defense Logistics Agency awarded a $13,737.99 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL syringes, with an ultimate completion date of September 12, 2025. This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a child contract...
- The Defense Logistics Agency awarded a $16,622.35 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Enbrel 50 mg/ml syringes. This firm fixed-price, non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order has a ceiling value of $224,446.26 and an ultimate completion date of September 26, 2025. The work will be performed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $58,286.34 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Enbrel 50 mg/mL syringes. The contract employs firm fixed pricing with no set-aside designation and is scheduled for completion by August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB26FGLYVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Enbrel 50 mg/ml syringes, with a ceiling value of $21,290.98. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under a larger indefinite delivery contract vehicle, reflecting AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical supply chain. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a prime vendor for the Defense Logistics Agency's Troop Support Medical division through a substantial $999,999,999.00 indefinite delivery contract (SPE2DX) extending through December 2026. This comprehensive contract vehicle enables the company to supply a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices, to support military healthcare programs globally. The current delivery order for Enbrel—a biologic treatment used for rheumatoid arthritis and other inflammatory conditions—exemplifies the company's ongoing role in fulfilling medical procurement needs across the Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 10/21/25 |